Is Inspire Medical Stock a Good Investment?

Inspire Medical Investment Advice

  INSP
To provide specific investment advice or recommendations on Inspire Medical Systems stock, we recommend investors consider the following general factors when evaluating Inspire Medical Systems. This will help you to make an informed decision on whether to include Inspire Medical in one of your diversified portfolios:
  • Examine Inspire Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Inspire Medical's leadership team and their track record. Good management can help Inspire Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Technology space and any emerging trends that could impact Inspire Medical's business and its evolving consumer preferences.
  • Compare Inspire Medical's performance and market position to its competitors. Analyze how Inspire Medical is positioned in terms of product offerings, innovation, and market share.
  • Check if Inspire Medical pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Inspire Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Inspire Medical Systems stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Inspire Medical Systems is a good investment.
 
Sell
 
Buy
Cautious Hold
Macroaxis provides investment recommendation on Inspire Medical to complement and cross-verify current analyst consensus on Inspire Medical Systems. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Inspire Medical Systems is not overpriced, please check out all Inspire Medical fundamentals, including its revenue, cash flow from operations, working capital, as well as the relationship between the cash per share and number of employees . Given that Inspire Medical Systems has a price to earning of 15.29 X, we strongly advise you to confirm Inspire Medical Systems market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very SmallDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Inspire Medical Stock

Researching Inspire Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company last dividend was issued on the January 9, 2008. Inspire Medical Systems had 1:10 split on the September 13, 2002.
To determine if Inspire Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inspire Medical's research are outlined below:
Inspire Medical generated a negative expected return over the last 90 days
Inspire Medical has high historical volatility and very poor performance
Inspire Medical is unlikely to experience financial distress in the next 2 years
Over 98.0% of the company shares are owned by institutional investors
Latest headline from kalkinemedia.com: Disposition of 204 shares by Bryan Phillips of Inspire Medical at 189.99 subject to Rule 16b-3
Inspire Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inspire Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inspire Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Inspire Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Inspire Medical's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-11-05
2019-09-30-0.41-0.340.0717 
2018-08-07
2018-06-30-0.51-0.430.0815 
2022-08-02
2022-06-30-0.62-0.530.0914 
2019-02-26
2018-12-31-0.31-0.220.0929 
2020-05-05
2020-03-31-0.57-0.67-0.117 
2019-08-06
2019-06-30-0.43-0.320.1125 
2023-05-02
2023-03-31-0.66-0.530.1319 
2018-11-06
2018-09-30-0.35-0.220.1337 

Know Inspire Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hhg Plc2024-12-31
567.3 K
Macquarie Group Ltd2024-12-31
537.6 K
Jpmorgan Chase & Co2024-12-31
519.5 K
Geode Capital Management, Llc2024-12-31
486.3 K
Artisan Partners Limited Partnership2024-12-31
450.2 K
Champlain Investment Partners, Llc2024-12-31
444.4 K
Aqr Capital Management Llc2024-12-31
438.8 K
Timessquare Capital Management, Llc2024-12-31
433.8 K
Frontier Capital Management Co Inc2024-12-31
418.9 K
Blackrock Inc2024-12-31
4.2 M
Vanguard Group Inc2024-12-31
3.3 M
Note, although Inspire Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inspire Medical's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.91 B.

Market Cap

5.79 Billion

Inspire Medical's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.07 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.07  0.07 
Return On Equity 0.08  0.08 
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Determining Inspire Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Inspire Medical is a good buy. For example, gross profit margin measures Inspire Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inspire Medical's profitability and make more informed investment decisions.

Inspire Medical's Earnings Breakdown by Geography

Evaluate Inspire Medical's management efficiency

Inspire Medical Systems has return on total asset (ROA) of 0.0304 % which means that it generated a profit of $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0848 %, meaning that it created $0.0848 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/26/2025, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.05. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 03/26/2025, Liabilities And Stockholders Equity is likely to grow to about 848.8 M, while Non Current Liabilities Total is likely to drop slightly above 24.2 M.
Last ReportedProjected for Next Year
Book Value Per Share 23.17  24.33 
Tangible Book Value Per Share 23.17  24.33 
Enterprise Value Over EBITDA 83.01  87.16 
Price Book Value Ratio 8.00  7.60 
Enterprise Value Multiple 83.01  87.16 
Price Fair Value 8.00  7.60 
Enterprise Value5.4 B5.7 B
Leadership at Inspire Medical emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta
1.479

Basic technical analysis of Inspire Stock

As of the 26th of March, Inspire Medical retains the Risk Adjusted Performance of (0.04), standard deviation of 3.24, and Market Risk Adjusted Performance of (0.17). Inspire Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Inspire Medical's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Inspire Medical's Outstanding Corporate Bonds

Inspire Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inspire Medical Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inspire bonds can be classified according to their maturity, which is the date when Inspire Medical Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Inspire Medical's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Inspire Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Inspire Medical's intraday indicators

Inspire Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Inspire Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Inspire Medical Corporate Filings

18th of March 2025
Other Reports
ViewVerify
F4
5th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
24th of February 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
12th of February 2025
Other Reports
ViewVerify
Inspire Medical time-series forecasting models is one of many Inspire Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inspire Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Inspire Stock media impact

Far too much social signal, news, headlines, and media speculation about Inspire Medical that are available to investors today. That information is available publicly through Inspire media outlets and privately through word of mouth or via Inspire internal channels. However, regardless of the origin, that massive amount of Inspire data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inspire Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inspire Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inspire Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inspire Medical alpha.

Inspire Medical Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Inspire Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Inspire Medical Systems Historical Investor Sentiment

Investor biases related to Inspire Medical's public news can be used to forecast risks associated with an investment in Inspire. The trend in average sentiment can be used to explain how an investor holding Inspire can time the market purely based on public headlines and social activities around Inspire Medical Systems. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Inspire Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inspire Medical and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Inspire Medical news discussions. The higher the estimate score, the more favorable the investor's outlook on Inspire Medical.

Inspire Medical Maximum Pain Price Across May 16th 2025 Option Contracts

Inspire Medical's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Inspire Medical close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Inspire Medical's options.

Inspire Medical Corporate Directors

Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.